On the contrary, the TFPI-2, originally identified by TFPI-1 homology as placental trypsin and serine protease inhibitor associated with tumour cell ECM [158–160], does not physiologically exert any inhibitory activity on the TF pathway [161]. This evidence concerns the gene TFPI2 and neoplasm.